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Circulating tumor cells (CTCs) act as an early biomarker representing metastatic cancer, in which
cells from a benign tumor release out into the bloodstream. These cells anchor to other organs of the
body and begin to use the tissue as a scaffold for growth, leading to rapid progression of cancer.
Metastatic cancer is at fault for the rise of breast, prostate, and brain cancer, which have high
mortality rates (606, 880 cancer deaths in the U.S).
Current  techniques  such  as  surgical  and  liquid  biopsies  are  invasive  and  inefficient  for  early
detection of cancer. In this work, we propose the capture and detection of CTCs using an antibody-
based  microfluidic  platform attached to  a  sensor  that  uses  electrical  impedance  to  sense  the
presence of cells. The change in capacitance correlates the number of cells captured on the sensor.
For  this  work,  we  selected  the  A549 lung  cancer  cell  line.  For  capturing  the  cancer  cells  a
microfluidic chamber was coated with antibodies specific to A549 cells which were connected to the
sensor that registered the presence of cells by creating an electrical impedance based on how many
cells attached to the antibodies.
The goal is to be able to register a small number of cells, around 10-50 cells/mL of sample. The
capture of a small number of cells assures early detection of cancer since in the initial stages of
cancer progression the number of CTCs would be quite low. If successful, then metastatic cancer
can be prevented through medical intervention at a stage where it can be completely removed. This
proposed method can verify the presence of a preexisting tumor, allowing for patients to eliminate a
cause for a new tumor to emerge.
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